1402
CLE
Graves' Disease
RA
100

What is the injection time for our new autoinjector?

Approximately 15 seconds

100

Can the screening period of the 1402 trial be extended?  If so, how long?

This period of the CLE trial may be extended by 2 weeks.

100

What is the duration of treatment Periods 1 and 2 on the Graves' Disease protocol?

26 weeks each for a total of 52 weeks

100

What are three options for patient dosing on the RA protocol?

In clinic, self-administration and home health vendors.

200

What are the preferable injection sites for 1402?

Abdominal quadrant, upper arm and thigh, right or left side of the body

200

What periods in the CLE trial are blinded to treatment assignment?

Period 1 and Period 3.

200

What types of drugs on the Graves' Disease protocol are Methimazole, carbimozole and propylthiouracil?

These are ATDs.

200

What is the observation time after the injection on the first two visits in the RA protocol?

30 minutes.

300

How does 1402 act upon IgG?

1402 blocks recycling of this substance and promotes its removal and degradation.

300

What three things that can be repeated once during the Screening Period?

Laboratory values, vital signs and ECGs.

300

During the proof of concept study for Graves' Disease, what was the noticeable finding at Week 12?

The timepoint by which most patients were off ATDs during the proof of concept study.

300

What optional procedure on the RA protocol may the patient also consent to?

Genetic testing.

400

What are characteristics of 1402 that have not been seen with other anti-FcRns?

Deep IgG lowering, favorable analyte profile and convenient administration

400

What is the value for the CLASE-A score at Screening and Day 1 if subject has alopecia or mucus membrane lesions?

The CLASE-A score must be >10 at Screening and Day if subject has alopecia or mucus membrane lesions.

400

In the proof of concept study, which important disease marker levels declined through Week 12?

TSHR autoantibody levels.

400

What is the primary study endpoint at Week 28 for the RA protocol?

ACR20 response.

500

What is the location on the FcRn molecule of the binding site for 1402?

The right side or opposite side from albumin.

500

When is the SLEDAI-2K score utilized and for which patients?

This assessment is required only for participants with SLE at baseline.

500

What does Lid Aperture measure?

The distance between the upper and lower eyelid.

500

What is the meaning for the term ACPA in the RA protocol?

Anti-citrullinated protein antibodies.